
Aspen Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: LegitScript-certified compounded semaglutide/tirzepatide with a named accredited pharmacy and flat dosing
Aspen stands out for its medical oversight and pharmacy verification.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Aspen (Aspen Health Systems LLC) is a LegitScript-certified telehealth clinic offering compounded semaglutide and tirzepatide as physician-chosen weekly injections, with flat pricing at every dose. Semaglutide is $279/mo and tirzepatide $399/mo month-to-month (less on prepay); even the monthly plan requires a 3-month commitment shipped upfront. Prescriptions are filled by Red Rock Compounding Pharmacy (NABP-accredited). Free expedited shipping, no insurance needed, and a money-back guarantee for patients who complete the 28-week program. Available in all 50 states and DC.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Aspen
RxSpan MD
Best for: shoppers wanting physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Aspen at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $279/mo (Month-to-month rate (3-month minimum commitment, 3 months shipped upfront, no credit check); drops to $229/mo (3-mo), $209/mo (6-mo) or $179/mo on the 12-month prepay plan.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Aspen
Each dimension is scored algorithmically from Aspen’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.1/10At $279/mo, Aspen runs about 65% above the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.4/10Aspen offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.6/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
9.0/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-18).
Accessibility10%
8.5/10Aspen treats patients in all 50 states.
Support10%
6.1/10Aspen provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Aspen review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with Aspen
We walked Aspen’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1You start an intake at /intake/weight-loss by choosing the weight-loss path; Aspen asks about your goals, health history and GLP-1 contraindications, framed as "a licensed provider will determine what's appropriate for you."
- 2You choose a plan — compounded semaglutide (from $179/mo on the 12-month prepay, up to $279 month-to-month) or tirzepatide (from $299/mo, up to $399) — though the provider ultimately selects the molecule ("physician chosen for you").
- 3You create an account and check out via Stripe; even the "monthly" plan bills a 3-month commitment with three months of medication shipped upfront, at zero interest and with no credit check.
- 4A licensed provider reviews your intake asynchronously (no routine video visit); if approved, medication is filled by Red Rock Compounding Pharmacy (or another U.S.-licensed partner) and shipped with free expedited shipping.
- 5Pricing is flat at every dose, and qualifying patients who complete the full 28-week program without losing weight are eligible for a full money-back refund. Month-to-month plans can be cancelled anytime by emailing help@startaspen.com.
- Aspen is LegitScript-certified (verifiable seal #50306023) and HIPAA-badged, and it names its compounding pharmacy — Red Rock Compounding Pharmacy (NABP-accredited, 49 states + DC) — stronger transparency than most compounded-GLP-1 sites.
- Pricing is fully published before intake: semaglutide $179–$279/mo and tirzepatide $299–$399/mo depending on plan length, with flat pricing at every dose and free expedited shipping.
- The commitment structure is the main catch — every plan, including the "monthly" one, requires a 3-month commitment with three months of medication billed and shipped upfront (zero interest, no credit check).
- It's an async, provider-selected model: the clinician chooses semaglutide vs tirzepatide for you and there is no routine video visit, so onboarding is fast but you don't pick your own molecule.
- A money-back guarantee applies only to qualifying patients who complete the full 28-week program without weight loss, and compounded medications are not FDA-approved. NOTE: this walkthrough is reconstructed from Aspen's public site and funnel; no account was created and no personal or health information was entered.
Aspen customer support
- Phone
- (307) 301-5303
- Hours
- Async care; email & phone support (hours not published)
GLP-1 medications Aspen offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Month-to-month rate (3-month minimum commitment, 3 months shipped upfront, no credit check); drops to $229/mo (3-mo), $209/mo (6-mo) or $179/mo on the 12-month prepay plan.
Aspen's "Most Prescribed" option; month-to-month rate drops to $329/mo (3-mo), $309/mo (6-mo) or $299/mo on the 12-month prepay plan. Same price at every dose.
Ready to get started?
Plans and promotions change often — check Aspen's current pricing and active discounts before you decide.
What we like
- LegitScript-certified with an independently verifiable seal (#50306023) and HIPAA compliance — a strong trust signal for a compounded-GLP-1 telehealth
- Names its dispensing pharmacy: Red Rock Compounding Pharmacy, LegitScript-certified and NABP-accredited, licensed in 49 states plus DC
- Flat pricing at every dose ("same price at every dose, no surprises") plus free expedited shipping, so your cost won't rise as you titrate up
- Competitive prepay rates — compounded semaglutide as low as $179/mo (12-mo) and tirzepatide $299/mo — with zero interest and no credit check
- Money-back guarantee for qualifying patients who complete the full 28-week program without losing weight; available in all 50 states + DC
Watch-outs
- Compounded semaglutide and tirzepatide only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
- Even the "monthly" plan requires a 3-month commitment with three months of medication shipped and billed upfront — limited month-to-month flexibility
- Standing month-to-month pricing is steep ($279 semaglutide, $399 tirzepatide); the lowest rates require 6- or 12-month prepay
- The provider chooses semaglutide vs tirzepatide for you, so you can't freely pick your own molecule
- Registered as Aspen Health Systems LLC at a Sheridan, WY address; async model with no routine video visit
Is Aspen worth it? Our verdict
Aspen positions itself around one thing: LegitScript-certified compounded semaglutide/tirzepatide with a named accredited pharmacy and flat dosing. It runs $279/month, flat across every dose — a premium to the category, so the extras need to justify it. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Aspen rounds out its offering with LegitScript-certified, Named accredited pharmacy, and Flat dose pricing.
How much Aspen actually costs
- Compounded semaglutide — $279/month
- Compounded tirzepatide — $399/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so Aspen's standing rate sits at the premium end.
For a direct comparison, Direct Meds runs semaglutide and tirzepatide from $249/month — worth pricing against Aspen before you commit.
Medications: what Aspen prescribes
Aspen prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Aspen is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Aspen treats patients in all 50 states, and dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Aspen costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, MyStart Health is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Aspen stands out for its medical oversight and pharmacy verification.
Ready to start with Aspen?
Starting at $279/month. See current pricing and start your free consultation.
Aspen might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider RxSpan MD.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Aspen review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Aspen's current pricing
Plans start at $279/month. Start your free consultation to check eligibility and today's price.